Ушбу иш иқтибос қилган ишлар

34 та иш

Иш: Tomato-made edible COVID-19 vaccine TOMAVAC induces neutralizing IgGs in the blood sera of mice and humans

Phytochrome RNAi enhances major fibre quality and agronomic traits of the cotton Gossypium hirsutum L
Ibrokhim Y. Abdurakhmonov, Zabardast T. Buriev, Sukumar Saha +3
Мақола201410 иқтибос
ABI
Profiling of the most reliable mutations from sequenced SARS-CoV-2 genomes scattered in Uzbekistan
Mirzakamol S. Ayubov, Zabardast T. Buriev, Mukhammadjon K. Mirzakhmedov +5
МақолаSARS-CoV-2 and COVID-19 ResearchPLoS ONE20229 иқтибос
ABI
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
Lianpan Dai, Tianyi Zheng, Kun Xu +18
Мақола20208 иқтибос
ABI
Сарлавҳасиз
Бошқа8 иқтибос
ABI
Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults
Lianpan Dai, Lidong Gao, Lifeng Tao +27
Мақола20227 иқтибос
ABI
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
Shilong Yang, Yan Li, Lianpan Dai +26
Мақола20216 иқтибос
ABI
Covid‐19 vaccines and variants of concern: A review
Ikbel Hadj Hassine
Шарҳ мақола20214 иқтибос
ABI
A plant‐derived edible vaccine against hepatitis B virus
Józef Kapusta, A. Modelska, Magdalena Figlerowicz +7
Мақола19992 иқтибос
ABI
Novel Transgenic Rice-Based Vaccines
Tatsuhiko Azegami, Hiroshi Itoh, Hiroshi Kiyono +1
Шарҳ мақола20142 иқтибос
ABI
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
Peter Pushko, Paul Pumpens, Elmars Grens
Шарҳ мақола20132 иқтибос
ABI
Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination
Tomonori Nochi, Hidenori Takagi, Yoshikazu Yuki +11
Мақола20072 иқтибос
ABI
Severe acute respiratory syndrome (SARS) S protein production in plants: Development of recombinant vaccine
Natalia Pogrebnyak, Maxim Golovkin, V. M. Andrianov +4
Мақола20052 иқтибос
ABI
Chloroplast‐derived vaccines against human diseases: achievements, challenges and scopes
Andreas Günter Lössl, Mohammad Tahir Waheed
Шарҳ мақола20112 иқтибос
ABI
Current state and challenges in developing oral vaccines
Julia E. Vela Ramirez, Lindsey A. Sharpe, Nicholas A. Peppas
Шарҳ мақола20172 иқтибос
ABI
Edible Vaccines: Promises and Challenges
Vrinda M Kurup, Jaya Thomas
Шарҳ мақола20192 иқтибос
ABI
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction
Chee Wah Tan, Wan Ni Chia, Xijian Qin +13
Мақола20202 иқтибос
ABI
An edible vaccine development for coronavirus disease 2019: the concept
Sayed Sartaj Sohrab
Шарҳ мақола20202 иқтибос
ABI
Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates
Konlavat Siriwattananon, Suwimon Manopwisedjaroen, Balamurugan Shanmugaraj +17
Мақола20212 иқтибос
ABI
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape
John S. Tregoning, Katie E. Flight, Sophie L. Higham +2
Шарҳ мақола20212 иқтибос
ABI
Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines
Puna Maya Maharjan, Sunghwa Choe
Шарҳ мақола20212 иқтибос
ABI
Protection against SARS-CoV-2 transmission by a parenteral prime—Intranasal boost vaccine strategy
Dennis Christensen, Charlotta Polacek, Daniel J. Sheward +17
Мақола20222 иқтибос
ABI
Mucosal COVID-19 vaccines: Risks, benefits and control of the pandemic
Dimitrina Miteva, Monika Peshevska-Sekulovska, Violeta Snegarova +3
Шарҳ мақола20222 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI